Merit Medical Systems | MMSI - Des Atouts





Des Atouts Changement Date
3M USD 39.53B 4.6B 2026-09
Abbott USD 110.43B 23.72B 2026-03
AngioDynamics USD 269.68M 4.04M 2025-09
Anika Therapeutics USD 183.47M 4.09M 2026-06
AtriCure USD 676.64M 32.66M 2026-06
Baxter International USD 19.41B 377M 2026-09
Becton, Dickinson and Co. USD 50.73B 101M 2026-06
Boston Scientific USD 45.22B 865M 2026-06
Cooper Companies USD 12.67B 191.1M 2026-06
Dexcom USD 6.24B 216.5M 2026-09
Edwards Lifesciences USD 13.87B 545.9M 2026-06
Globus Medical USD 5.49B 48.7M 2026-06
Haemonetics USD 2.37B 30.52M 2026-06
ICU Medical USD 3.97B 42.48M 2026-06
Insulet USD 3.17B 177.9M 2026-06
Integra LifeSciences USD 3.51B 55.69M 2026-09
J&J USD 197.42B 3.64B 2026-09
Medtronic USD 93.31B 278M 2026-06
Merit Medical Systems USD 2.92B 61.29M 2026-09
Olympus JPY 1.53T 10.69B 2026-06
Pfizer USD 201.13B 6.49B 2026-06
STAAR Surgical USD 475.2M 24.09M 2026-06
Stryker USD 47.93B 1.64B 2026-06
Tandem Diabetes Care USD 1.15B 808K 2026-06
Teleflex USD 6.79B 3.78M 2026-06
Terumo JPY 2.37T 61.86B 2026-06
Zimmer Biomet Holdings USD 22.8B 76.2M 2026-06